Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas

Shoib S Siddiqui; Michael Vaill; Ajit Varki

doi:10.1096/fba.2021-00036

Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas

Shoib S Siddiqui, Michael Vaill, Ajit Varki

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	278-279
Number of pages	2
Journal	FASEB BioAdvances
Volume	3
Issue number	4
Early online date	15 Mar 2021
DOIs	https://doi.org/10.1096/fba.2021-00036
Publication status	Published - 3 Apr 2021

Access to Document

10.1096/fba.2021-00036Licence: CC BY

Cite this

@article{ea179daee4dc4943b8626d468f8ecb7a,

title = "Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas",

author = "Siddiqui, {Shoib S} and Michael Vaill and Ajit Varki",

year = "2021",

month = apr,

day = "3",

doi = "10.1096/fba.2021-00036",

language = "English",

volume = "3",

pages = "278--279",

journal = "FASEB BioAdvances",

issn = "2573-9832",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas

AU - Siddiqui, Shoib S

AU - Vaill, Michael

AU - Varki, Ajit

PY - 2021/4/3

Y1 - 2021/4/3

UR - http://www.scopus.com/inward/record.url?scp=85106317166&partnerID=8YFLogxK

U2 - 10.1096/fba.2021-00036

DO - 10.1096/fba.2021-00036

M3 - Letter

C2 - 33842853

SN - 2573-9832

VL - 3

SP - 278

EP - 279

JO - FASEB BioAdvances

JF - FASEB BioAdvances

IS - 4

ER -

Ongoing selection for a uniquely human null allele of SIGLEC12 in world-wide populations may protect against the risk of advanced carcinomas

Access to Document

Other files and links

Cite this